CRIMPING TOOL - 9446 Anuncios
401120 MedicinaReportar abuso
Wednesday 13 August 2025
Cantidad : 60mg*10via - Precio : USD 650
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicinaReportar abuso
Wednesday 13 August 2025
Cantidad : 50mg*10via - Precio : USD 550
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicinaReportar abuso
Wednesday 13 August 2025
Cantidad : 40mg*10via - Precio : USD 450
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicinaReportar abuso
Wednesday 13 August 2025
Cantidad : 30mg*10via - Precio : USD 360
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicinaReportar abuso
Wednesday 13 August 2025
Cantidad : 20mg*10via - Precio : USD 300
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MedicinaReportar abuso
Wednesday 13 August 2025
Cantidad : 15mg*10via - Precio : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
